Milo Gatti, Eleonora Turrini, Emanuel Raschi, Piero Sestili, & Carmela Fimognari. (2021). Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues. MDPI AG.
Chicago Style (17th ed.) CitationMilo Gatti, Eleonora Turrini, Emanuel Raschi, Piero Sestili, and Carmela Fimognari. Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues. MDPI AG, 2021.
MLA (9th ed.) CitationMilo Gatti, et al. Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues. MDPI AG, 2021.
Warning: These citations may not always be 100% accurate.